Invizyne Technologies Inc financial data

Symbol
IZTC
Industry
Biological Products, (No Diagnostic Substances)
Location
750 Royal Oaks Dr, Monrovia, CA
State of incorporation
NV
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 12, 2024

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 6.25M shares
Common Stock, Shares, Outstanding 6.25M shares
Common Stock, Value, Issued 6 USD
Weighted Average Number of Shares Outstanding, Basic 6.25M shares +0.04%
Weighted Average Number of Shares Outstanding, Diluted 6.25M shares +0.04%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 723K USD +2490%
General and Administrative Expense 888K USD +144%
Operating Income (Loss) -1.61M USD -311%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -1.66M USD -218%
Net Income (Loss) Attributable to Parent -1.66M USD -218%
Earnings Per Share, Basic -0.27 USD/shares -238%
Earnings Per Share, Diluted -0.27 USD/shares -238%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 234K USD
Assets, Current 1.42M USD
Property, Plant and Equipment, Net 740K USD
Operating Lease, Right-of-Use Asset 1.4M USD
Assets 3.56M USD
Accounts Payable, Current 909K USD
Liabilities, Current 5.8M USD
Operating Lease, Liability, Noncurrent 1.22M USD
Liabilities 7.16M USD
Retained Earnings (Accumulated Deficit) -10.1M USD
Stockholders' Equity Attributable to Parent -3.6M USD -693%
Liabilities and Equity 3.56M USD

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 100M shares
Common Stock, Shares, Issued 6.25M shares
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 234K USD -50.7%
Operating Lease, Liability 1.45M USD
Depreciation 68.9K USD +38.5%
Lessee, Operating Lease, Liability, to be Paid 1.73M USD
Property, Plant and Equipment, Gross 1.4M USD
Operating Lease, Liability, Current 224K USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 358K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 349K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 287K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 368K USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares
Lessee, Operating Lease, Liability, to be Paid, Year Four 379K USD
Additional Paid in Capital 6.51M USD
Preferred Stock, Shares Outstanding 0 shares
Interest Expense 44.6K USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares